Expression of Epstein–Barr Virus Membrane Antigen gp340/220 in Mouse Fibroblasts Using a Bovine Papillomavirus Vector

References

1. Biggin M., Farrell P. J., Barrell B. G. 1984; Transcription and DNA sequence of the BamHIL fragment of B95-8 Epstein–Barr virus. EMBO Journal 3:1083–1090
   [Google Scholar]
2. David E. M., Morgan A. J. 1988; Efficient purification of Epstein–Barr virus membrane antigen gp340 by fast protein liquid chromatography. Journal of Immunological Methods 108:231–236
   [Google Scholar]
3. De Thé G., Geser A., Day N. E., Tukei P. M., Williams E. H., Beri D. P., Smith P. G., Dean A. G., Bornkamm G. W., Feorino P., Henle W. 1978; Epidemiological evidence for causal relationship between Epstein–Barr virus and Burkitt’s lymphoma from Ugandan prospective study. Nature, London 274:756–761
   [Google Scholar]
4. Epstein M. A. 1976; Epstein–Barr virus—is it time to develop a vaccine programme?. Journal of the National Cancer Institute 56:697–700
   [Google Scholar]
5. Epstein M. A., Morgan A. J., Finerty S., Randle B. J., Kirkwood J. K. 1985; Protection of cottontop tamarins against Epstein–Barr virus-induced malignant lymphoma by a prototype subunit vaccine. Nature, London 318:287–289
   [Google Scholar]
6. Hoffman H. I., Lazarowitz S. G., Hayward S. D. 1980; Monoclonal antibody against a 250,000 dalton glycoprotein of Epstein–Barr virus identifies a membrane antigen and neutralizing antigen. Proceedings of the National Academy of SciencesU.S.A 772979–2983
   [Google Scholar]
7. Hummel M., Thorley-Lawson D. A., Kieff E. 1984; An EBV DNA fragment encodes messages for the two major envelope glycoproteins (gp 350/300 and gp 220/200). Journal of Virology 49:413–417
   [Google Scholar]
8. Mackett M., Arrand I. R. 1985; Recombinant vaccinia virus induces neutralising antibodies in rabbits against Epstein–Barr virus membrane antigen gp 340. EMBO Journal 4:3229–3234
   [Google Scholar]
9. Morgan A. J., Finerty S., Lovgren K., Scullion F. T., Morein B. 1988; Prevention of Epstein–Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes. Journal of General Virology 69:2093–2096
   [Google Scholar]
10. Motz M., Deby G., Jilg W., Wolf H. 1986; Expression of the Epstein–Barr virus major membrane proteins in Chinese hamster ovary cells. Gene 44:353–359
    [Google Scholar]
11. Motz M., Deby G., Wolf H. 1987; Truncated versions of the two major Epstein–Barr viral glycoproteins (gp 250/350) are secreted by recombinant Chinese hamster ovary cells. Gene 58:149–154
    [Google Scholar]
12. Parkin D. M., Stjernsward J., Muir C. S. 1984; Estimates of the worldwide frequency of twelve major cancers. Bulletin of the World Health Organization 62:163–182
    [Google Scholar]
13. Pavlakis G. N., Hamer D. H. 1983; Regulation of a metallothionein-growth hormone hybrid gene in bovine papillomavirus. Proceedings of the National Academy of SciencesU.S.A 80397–401
    [Google Scholar]
14. Pearson G., Dewey F., Klein G., Henle G., Henle W. 1970; Relation between neutralization of Epstein–Barr virus and antibodies to cell membrane antigens induced by the virus. Journal of the National Cancer Institute 45:989–995
    [Google Scholar]
15. Sambrook J., Rodoers L., White J., Gethig M. J. 1985; Lines of BPV transformed murine cells that constitutively express influenza virus haemagglutinin. EMBO Journal 4:91–103
    [Google Scholar]
16. Schultz L. D., Tanner J., Hofmann K. J., Emini E. A., Condra J. H., Jones R. E., Keiff E., Ellis R. W. 1987; Expression and secretion of a yeast 400Kd envelope glycoprotein derived from Epstein–Barr virus. Gene 54:113–123
    [Google Scholar]
17. Simons M. J., Shanmugaratnam K. 1982; The biology of nasopharyngeal carcinoma. UICC Technical Report 71:
    [Google Scholar]
18. Tanner J., Weis J., Fearon D., Whang Y., Keiff E. 1987; Epstein–Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell 50:203–213
    [Google Scholar]
19. Thorley-Lawson D. A., Geilinger K. 1980; Monoclonal antibodies against the major glycoprotein (gp 350/220) of Epstein–Barr virus neutralize infectivity. Proceedings of the National Academy of SciencesU.S.A 775307–5311
    [Google Scholar]
20. Thorley-Lawson D. A., Poodry C. A. 1982; Identification and isolation of the main component (gp 350/gp 220) of Epstein–Barr virus responsible for generating neutralizing antibodies in vivo. Journal of Virology 43:730–736
    [Google Scholar]
21. Whang Y., Silberklang M., Morgan A., Munshi S., Lenny A. B., Ellis R. W., Keiff E. 1987; Expression of the Epstein–Barr virus gp350-220 gene in rodent and primate cells. Journal of Virology 61:1796–1807
    [Google Scholar]